Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Stomach Disorders
•
Primary Care
How do you manage a patient who is reliant on NSAIDs for arthritis but has developed PUD?
Would you consider COX-2 selective inhibition, PPI, PCAB, or some combination thereof?
Related Questions
Can rapid weight loss following GLP1 R agonist therapy lead to postprandial hypoglycemia and if so, what are the treatment options outside of dietary modifications?
How do you decide between anticoagulation and observation for an incidentally detected subsegmental pulmonary embolism in elderly patients with a history of gastrointestinal bleeding?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
What prompts you to seek an alternative PPI versus escalating to PCAB therapy in patients with symptoms and sequelae of GERD who have clinically failed one PPI trial despite appropriate pre-prandial use?
How do you approach surveillance of gastric hyperplastic polyps of various sizes?
How do you approach the treatment of microscopic colitis?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
Do you routinely check vitamin K levels in post-bariatric surgery patients?
What role do you feel there is for antibiotics in the management of severe perianal Crohn's disease?
Are there data to support the use of herbal supplements, prebiotics, or probiotics in the management of SIBO?